Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Published December 3, 2025 · Recall initiated: November 6, 2025
Summary
FDA records drug Class I recall D-0182-2026, published December 3, 2025 and initiated November 6, 2025. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 2,199,850 vials; Lot: Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if FAMOTIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FAMOTIDINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide within the United States as well as AK, HI, and PR.
- UPC
- 0363323739119
- Lot
- Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFamotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only,September 9, 2026
- FDAWalgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD.,December 3, 2025
- FDADoctor. D. Schwab Mineral Sunscreen SPF 50, Zinc Oxide 21%, 4 oz./ 113.4 g per tube, Manufactured by CADecember 3, 2025
- FDAFamotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc.,July 26, 2023
- FDAFamotidine Tablets USP 40mg, 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279March 10, 2021
- FDAFamotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only AfterJuly 29, 2020
Questions about this recall
Was Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale). recalled?
Yes. FDA published recall D-0182-2026 on December 3, 2025. Reported hazard: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FAMOTIDINE. UPC: 0363323739119.